Huntington ‘s disease – Page 2 – Talk Bio

Actionable Insights Powered by AI

Huntington’s Disease Clinical Trials: Updates on Dalzanemdor and Tominersen

11 months ago talkbio0Tagged Clinical Trials, dalzanemdor, Huntington 's disease, Impaired cognition, NMDA receptor modulator, Phase 2, Phase 3 studies, RNA-based therapy, tominersen

Huntington’s disease, clinical trials, dalzanemdor, tominersen, cognitive impairment, RNA-based therapy, NMDA receptor modulator, Phase 2 and Phase 3 studies